Source briefing
First European Medicines Agency (EMA) and Active Pharmaceutical Ingredients Committee (APIC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 September 2026, 15:30 (CEST) to 2 September 2026, 17:30 (CEST)
First European Medicines Agency (EMA) and Active Pharmaceutical Ingredients Committee (APIC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 September 2026, 15:30 (CEST) to 2 September 2026, 17:30 (CEST)
Read →
Source briefing
Real-world data collection in Duchenne muscular dystrophy: Joint Heads of Medicines Agencies (HMA) / European Medicines Agency (EMA) multistakeholder workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 09:00 (CEST) to 25 September 2026, 17:30 (CEST)
Real-world data collection in Duchenne muscular dystrophy: Joint Heads of Medicines Agencies (HMA) / European Medicines Agency (EMA) multistakeholder workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 09:00 (CEST) to 25 September 2026,…
Read →Source briefing
Trump’s Latest Media Attacks Again Hit Women Journalists
Click to expand Image MS NOW White House Correspondent Akayla Gardner prepares for a television report on a street corner outside the White House grounds in Washington, DC, on September 21, 2026. © 2026 Andrew Thomas/NurPhoto via AP…
Read →Source briefing
Regulatory Perspectives on Herbal Medicinal / Botanical Drug Product Development: Joint FDA / EMA Workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 10:00 (CEST) to 25 September 2026, 13:00 (CEST)
Regulatory Perspectives on Herbal Medicinal / Botanical Drug Product Development: Joint FDA / EMA Workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 10:00 (CEST) to 25 September 2026, 13:00 (CEST)
Read →Source briefing
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Read →Source briefing
Correction: Evaluation of splenic accumulation and colocalization of immature reticulocytes and <i>Plasmodium vivax</i> in asymptomatic malaria: A prospective human splenectomy study
by Steven Kho, Labibah Qotrunnada, Leo Leonardo, Benediktus Andries, Putu A. I. Wardani, Aurelie Fricot, Benoit Henry, David Hardy, Nur I. Margyaningsih, Dwi Apriyanti, Agatha M. Puspitasari, Pak Prayoga, Leily Trianty, Enny Kenangalem, Fabrice Chretien, Valentine Brousse, Innocent…
Read →Source briefing
Global, regional, and national impact of epidemic disasters on health workforce equality between 1990 and 2019: An ecological and modeling study
by Manman Chen, Wanzhou Wang, Feng Sha, Zichen Ye, Yuankai Zhao, Chao Yang, Ze Liang, Yu Jiang, Xijie Wang, Jinling Tang Background Global distribution of human resources for health (HRH) is highly unequal and less resourced regions may…
Read →
Source briefing
Is it time to start cutting red tape on government programs?
Journalist’s new book argues ‘administrative burden’ unfairly hits nation’s most vulnerable hardest, suggests solutions
Read →Source briefing
Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Date of authorisation: 20/06/2002, Revision: 49, Status: Authorised
Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Date of authorisation: 20/06/2002, Revision: 49, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA vaccine, Date of authorisation: 20/04/2026, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA vaccine, Date of authorisation: 20/04/2026, Revision: 1, Status: Authorised
Read →